Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Individual Patient Dose-Escalated Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease in Children and Adults: Safety, Efficacy and Immune Correlates

Blood (2017) 130 (Supplement 1): 3248.

https://doi.org/10.1182/blood.V130.Suppl_1.3248.3248

Published: 2017

Journal Articles

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocyteic Leukemia Patients Who Underwent Reduced Intensity Conditioning Allogeneit HCT: A CIBMTR Report

Haesook T Kim, PhD, Zhen-Huan Hu, MPH, Kwang Woo Ahn, PhD, Matthew Davids, MD, Virginia Volpe, MD, Edwin Alyea, MD, Uday Popat, MD, Ronald Sobecks, MD, Wael Saber, MD MS, Jennifer Brownn, MD PhD

Blood (2017) 130 (Supplement 1): 667.

https://doi.org/10.1182/blood.V130.Suppl_1.667.667

Published: 2017

Journal Articles

Optimal Timing of Allogeneic Stem Cell Transplantation (Allo-SCT) for Chronic Myeloid Leukemia (CML) Patients in the Tyrosine Kinase Inhibitor (TKI) Era

Bei Hu, Xiao Lin, ^, Hans C. Lee, MD, Xuelin Huang, PhD, Rebecca Slack, MS, Elias J. Jabbour, MD, Srdan Verstovsek, MD PhD, Farhad Ravandi, MBBS, Guillermo Garcia-Manero, MD, Richard E Champlin, MD, Zhen-Huan Hu, MPH, Kwang Woo Ahn, PhD, Ying Lee, MD, Uday Popat, MD, Ronald Sobecks, MD, Edwin Alyea, MD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD, Wael Saber, MD MS

Blood (2017) 130 (Supplement 1): 4582.

https://doi.org/10.1182/blood.V130.Suppl_1.4582.4582

Published: 2017

Journal Articles

Phase I Trial of Regulatory T-Cell Donor Lymphocyte Infusion Plus Daily Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Versus-Host Disease

Blood (2017) 130 (Supplement 1): 511.

https://doi.org/10.1182/blood.V130.Suppl_1.511.511

Published: 2017

Journal Articles

Assessment of Human Leukocyte Antigen (HLA) Type on Outcomes of Allogeneic Transplant for Chronic Lymphocytic Leukemia (CLL)

Brian T. Hill, MD PhD, Kwang Woo Ahn, PhD, Zhen-Huan Hu, MPH, Matt Kalaycio, MD FACP, Richard T. Maziarz, MD, Jorge E. Cortes, MD, Edwin Alyea, MD, Uday R. Popat, MD, Ronald M. Sobecks, MD, Wael Saber, MD MS

Blood (2016) 128 (22): 2256.

https://doi.org/10.1182/blood.V128.22.2256.2256

Published: 2016

Journal Articles

A Prognostic System Predictive of Outcomes in Persons Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Brian C Shaffer, MD, Kwang Woo Ahn, PhD, Zhen-Huan Hu, MPH, Uday R. Popat, MD, Matt Kalaycio, MD, Richard T. Maziarz, MD, Edwin Alyea, MD, Ron M Sobecks, MD, Steven Z. Pavletic, MD, Martin S Tallman, MD, Wael Saber, MD MS

Blood (2015) 126 (23): 64.

https://doi.org/10.1182/blood.V126.23.64.64

Published: 2015

Journal Articles

Allele Matching At HLA-C or DRB1 Is Associated with Improved Survival After Reduced Intensity Double Umbilical Cord Blood Transplantation

Alfred L. Garfall, MD, Haesook T Kim, PhD, Corey Cutler, MD, MPH, FRCPC, Vincent T Ho, MD, John Koreth, MBBS, DPhil, Philippe Armand, MD, PhD, Yi-Bin A. Chen, MD, Steven L. McAfee, MD, Bimalangshu R. Dey, MD, Deborah Liney, Edwin Alyea, MD, Robert J. Soiffer, MD, Thomas R. Spitzer, MD, Joseph H. Antin, MD, Karen K. Ballen, MD

Blood (2012) 120 (21): 2010.

https://doi.org/10.1182/blood.V120.21.2010.2010

Published: 2012

Journal Articles

Impact of White Blood Cell Count Recovery On Clinical Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation

Haesook T Kim, PhD, David G Frederick, Emily Andler, Philippe Armand, MD, PhD, Grace Kao, MD, Corey Cutler, MD, MPH, FRCPC, John Koreth, MBBS, DPhil, Edwin Alyea, MD, Joseph H Antin, MD, Robert J Soiffer, MD, Jerome Ritz, MD, Vincent T. Ho, MD

Blood (2012) 120 (21): 4136.

https://doi.org/10.1182/blood.V120.21.4136.4136

Published: 2012

Journal Articles

Immune Reconstitution After Cord Blood Transplantation in Adults Depends on Activity of Thymic Epithelial Cells and Vascular Endothelial Elements,

Julia Brown, PhD, Haesook T Kim, PhD, Corey Cutler, MD, MPH, FRCPC, Sean McDonough, Edwin Alyea, MD, Vincent Ho, MD, Eyal C. Attar, MD, Bimalangshu R. Dey, MD, Steven L. McAfee, MD, Thomas Spitzer, MD, Robert J Soiffer, MD, Jerome Ritz, MD, Joseph H Antin, MD, Karen K. Ballen, MD, Vassiliki A Boussiotis, MD, PhD

Blood (2011) 118 (21): 4075.

https://doi.org/10.1182/blood.V118.21.4075.4075

Published: 2011

Journal Articles

KIR-Ligand Incompatibility Is Not Associated with Relapse Reduction After Double Umbilical Cord Blood Transplantation,

Alfred L Garfall, MD, Haesook T Kim, PhD, Lixian Sun, MS, Vincent T Ho, MD, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Edwin Alyea, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Corey S. Cutler, MD, MPH, FRCPC

Blood (2011) 118 (21): 4150.

https://doi.org/10.1182/blood.V118.21.4150.4150

Published: 2011

Journal Articles

Adenovirus Infections in Patients Undergoing Umbilical Cord Blood Hematopoietic Stem Cell Transplantation.

Gabriela Soriano, MD, Vincent T Ho, MD, Karen K Ballen, MD, Philippe Armand, MD, PhD, Corey Cutler, MD, MPH, John Koreth, MBBS, DPhil, Edwin Alyea, MD, Robert J Soiffer, MD, Lindsey Baden, MD, Joseph H Antin, MD, Francisco M Marty, MD

Blood (2009) 114 (22): 1132.

https://doi.org/10.1182/blood.V114.22.1132.1132

Published: 2009

Journal Articles

Comparative Outcome of Myeloablative and Reduced Intensity Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.

Jennifer R Brown, MD, PhD, Kristen Stevenson, Haesook T. Kim, Philippe Armand, MD, PhD, Corey Cutler, David C. Fisher, Vincent Ho, John Koreth, Jerome Ritz, Joseph H. Antin, Robert J. Soiffer, John G. Gribben, MD, DSc, Edwin Alyea, MD

Blood (2008) 112 (11): 972.

https://doi.org/10.1182/blood.V112.11.972.972

Published: 2008

Journal Articles

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

Vincent Ho, MD, Glenn Dranoff, MD, Haesook Kim, PhD, Matthew Vanneman, Mildred Pasek, Corey Cutler, MD, John Koreth, MBBS, Edwin Alyea, MD, Joseph H Antin, MD, Ritz Jerome, MD, Robert J Soiffer, MD

Blood (2008) 112 (11): 825.

https://doi.org/10.1182/blood.V112.11.825.825

Published: 2008

Journal Articles

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Meghan Delaney, DO, Beow Yeap, Sc.D, Richard L. Haspel, MD, PhD, Thomas R. Spitzer, MD, Steven L. McAfee, MD, Bimalangshu Dey, MD, PhD, Eyal Attar, MD, Grace Kao, MD, Edwin Alyea, MD, Stephanie Lee, MD, Corey Cutler, MD, Vincent Ho, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Ballen Karen, MD

Blood (2007) 110 (11): 2032.

https://doi.org/10.1182/blood.V110.11.2032.2032

Published: 2007

Journal Articles

Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.

Corey Cutler, MD, MPH, FRCPC, Rachel Mitrovich, Grace Kao, MD, Vincent Ho, MD, Edwin Alyea, MD, John Koreth, MBBS, Philippe Armand, MD, Bimalangshu Dey, MD, Thomas Spitzer, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Karen Ballen, MD

Blood (2007) 110 (11): 2016.

https://doi.org/10.1182/blood.V110.11.2016.2016

Published: 2007

Journal Articles

Immunoproteomic Identification of Graft-Versus-Leukemia Targets in Patients with Chronic Lymphocytic Leukemia.

Ovidiu Marina, MS, Melinda Biernacki, Ann Cai, Wandi Zhang, Jonathan S. Duke-Cohan, PhD, Vladimir Brusic, PhD, Fenglong Liu, PhD, Edwin Alyea, MD, Christine M. Canning, Robert Soiffer, MD, Jerome Ritz, MD, Catherine J. Wu, MD

Blood (2007) 110 (11): 71.

https://doi.org/10.1182/blood.V110.11.71.71

Published: 2007

Journal Articles

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Julia Brown, PhD, Karen Ballen, MD, Sean McDonough, Xupeng Ge, MD, PhD, Kristen Stevenson, PhD, Haesook Kim, PhD, Carol Reynolds, Bimalangshu R. Dey, MD, PhD, Steve McAfee, MD, Eyal Attar, MD, Thomas Spitzer, MD, Corey Cutler, MD, Vincent Ho, MD, Edwin Alyea, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2007) 110 (11): 1057.

https://doi.org/10.1182/blood.V110.11.1057.1057

Published: 2007

Journal Articles

GM-CSF Secreting Leukemia Cell Vaccinations after Allogeneic Reduced-Intensity Peripheral Blood Stem Cell Transplantation (SCT) for Advanced Myelodysplastic Syndrome (MDS) or Refractory Acute Myeloid Leukemia (AML).

Vincent Ho, MD, Glenn Dranoff, MD, Haesook Kim, PhD, Mildred Pasek, RN, Corey Cutler, MDMPH, Edwin Alyea, MD, John Koreth, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD

Blood (2006) 108 (11): 3680.

https://doi.org/10.1182/blood.V108.11.3680.3680

Published: 2006

Journal Articles

Long-Term Outcome of Methotrexate-Free GVHD Prophylaxis Using Sirolimus and Tacrolimus in Matched Related (MRD) and Unrelated Donor (URD) Peripheral Blood Stem Cell Transplantation (PBSCT).

Corey Cutler, MD, MPH, FRCP, Shuli Li, MS, Vincent Ho, MD, John Koreth, MBBS, Edwin Alyea, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD

Blood (2006) 108 (11): 757.

https://doi.org/10.1182/blood.V108.11.757.757

Published: 2006

Journal Articles

Outcomes of 40 Adult Patients after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Conditioning Regimen.

Karen K. Ballen, MD, Corey Cutler, MD, Thomas R. Spitzer, MD, Beow Yeap, ScD, Steve McAfee, MD, Bimalangshu R. Dey, MD, Eyal Attar, MD, Richard L. Haspel, MD, PhD, Edwin Alyea, MD, Vincent Ho, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD

Blood (2006) 108 (11): 605.

https://doi.org/10.1182/blood.V108.11.605.605

Published: 2006

NARROW

Individual Patient Dose-Escalated Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease in Children and Adults: Safety, Efficacy and Immune Correlates

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocyteic Leukemia Patients Who Underwent Reduced Intensity Conditioning Allogeneit HCT: A CIBMTR Report

Optimal Timing of Allogeneic Stem Cell Transplantation (Allo-SCT) for Chronic Myeloid Leukemia (CML) Patients in the Tyrosine Kinase Inhibitor (TKI) Era

Phase I Trial of Regulatory T-Cell Donor Lymphocyte Infusion Plus Daily Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Versus-Host Disease

Assessment of Human Leukocyte Antigen (HLA) Type on Outcomes of Allogeneic Transplant for Chronic Lymphocytic Leukemia (CLL)

A Prognostic System Predictive of Outcomes in Persons Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Allele Matching At HLA-C or DRB1 Is Associated with Improved Survival After Reduced Intensity Double Umbilical Cord Blood Transplantation

Impact of White Blood Cell Count Recovery On Clinical Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation

Immune Reconstitution After Cord Blood Transplantation in Adults Depends on Activity of Thymic Epithelial Cells and Vascular Endothelial Elements,

KIR-Ligand Incompatibility Is Not Associated with Relapse Reduction After Double Umbilical Cord Blood Transplantation,

Adenovirus Infections in Patients Undergoing Umbilical Cord Blood Hematopoietic Stem Cell Transplantation.

Comparative Outcome of Myeloablative and Reduced Intensity Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.

Immunoproteomic Identification of Graft-Versus-Leukemia Targets in Patients with Chronic Lymphocytic Leukemia.

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

GM-CSF Secreting Leukemia Cell Vaccinations after Allogeneic Reduced-Intensity Peripheral Blood Stem Cell Transplantation (SCT) for Advanced Myelodysplastic Syndrome (MDS) or Refractory Acute Myeloid Leukemia (AML).

Long-Term Outcome of Methotrexate-Free GVHD Prophylaxis Using Sirolimus and Tacrolimus in Matched Related (MRD) and Unrelated Donor (URD) Peripheral Blood Stem Cell Transplantation (PBSCT).

Outcomes of 40 Adult Patients after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Conditioning Regimen.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only